A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery | NCT00521456 | Trialant
CompletedInterventionalPhase 3Updated Oct 1, 2009
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
ClinicalTrials.gov ID
NCT00521456
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
263Actual
Last Update Posted
Oct 1, 2009Estimated
Start Date
Oct 2007
Primary Completion Date
Mar 2008Actual
Completion Date
Mar 2008Actual
Brief Summary
This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery
Cataract Extraction
ketorolac eye drops
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing cataract surgery
Exclusion Criteria:
Uncontrolled ocular disease in cataract surgery eye